Sponsor hub
Teva Branded Pharmaceutical Products R&D, Inc. clinical trial failures
Review 28 stopped clinical trials from Teva Branded Pharmaceutical Products R&D, Inc., including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 6 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 13
- OTHER/UNKNOWN
- 9
- EFFICACY/FUTILITY
- 6
Notable sponsors
- Teva Branded Pharmaceutical Products R&D, Inc.
- 28
Related phases
- Phase III
- 14
- Phase II
- 7
- Phase I
- 4
- Phase IV
- 3
Crawlable stopped-trial records
Open ExploreShowing up to 28 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase III Cerebral Palsy, Dyskinetic trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
Failure of TV50717-CNS-30080 (parent study) to meet the primary efficacy endpoint
Phase I Solid Tumors trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Stopped for strategic reasons
Phase II Fibromyalgia trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: EFFICACY/FUTILITY.
Met pre-specified criteria for futility at interim analysis
Phase II Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: EFFICACY/FUTILITY.
Met pre-specified criteria for futility at interim analysis
Phase III Eosinophils, Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
Parent Studies didn't meet their primary endpoint so study was terminated.
Phase III Healthy Participants trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Study was terminated due to low enrollment
Phase III Growth Hormone Deficiency trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business decision
Phase III Growth Hormone Deficiency trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business decision
Phase III Relapsing Multiple Sclerosis trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose.
Phase III Relapsing Multiple Sclerosis trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose
Phase IV Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Very poor enrollment
Phase IV Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
The study was terminated early due to challenges in recruitment. The decision to terminate the study was not related to any safety issues or concerns.
Phase III Relapsing Remitting Multiple Sclerosis trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business Decision
Phase III Cluster Headache trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: EFFICACY/FUTILITY.
The study was terminated after the episodic cluster study was terminated due to a pre specified futility analyses
Phase III Tourette Syndrome trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: EFFICACY/FUTILITY.
The parent trials did not meet the primary endpoints of reduction in motor and phonic tics.
Phase I Chronic Myeloid Leukemia trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Inability to accrue additional sites and enroll an adequate number of subjects.
Phase II Chronic Obstructive Pulmonary Disease trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Episodic Cluster Headache trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: EFFICACY/FUTILITY.
Study was terminated as a result of a pre-specified futility analysis at the interim of 150 participants completing the efficacy analysis of the study.
Phase II Interstitial Cystitis trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
Withdrawn due to logistic reasons
Phase III Chronic Cluster Headache trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: EFFICACY/FUTILITY.
Futility analysis revealed that the primary endpoint is unlikely to be met. There were no safety concerns observed with fremanezumab treatment in the trial.
Phase I Chronic Obstructive Pulmonary Disease trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business decision
Phase II Nonalcoholic Steatohepatitis trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business decision
Phase I Chronic Obstructive Pulmonary Disease (COPD trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business decision
Phase IV Stable Renal Transplant Recipients trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Slow recruitment and lack of time to product launch
Phase III Eosinophilic Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OPERATIONAL.
Business decision
Phase III Asthma trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
Change to study required.
Phase II Solid Tumors trial by Teva Branded Pharmaceutical Products R&D, Inc.. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.